SAN FRANCISCO, Feb. 3, 2026 /PRNewswire/ — Michroma, a biotechnology company developing high-performance, scalable natural food colorants through precision fermentationSAN FRANCISCO, Feb. 3, 2026 /PRNewswire/ — Michroma, a biotechnology company developing high-performance, scalable natural food colorants through precision fermentation

Fernando Miquelarena Joins Michroma as Independent Board Director

2 min read

SAN FRANCISCO, Feb. 3, 2026 /PRNewswire/ — Michroma, a biotechnology company developing high-performance, scalable natural food colorants through precision fermentation, today announced that Fernando Miquelarena has joined its Board of Directors as an Independent Board Director, following more than two years working with the company as a Board Advisor.

Fernando brings nearly 30 years of global leadership, driving commercial success across the food, beverage, ingredients, and consumer goods industries. He has built and led businesses across the Asia-Pacific and the Americas, with proven expertise in translating innovative technologies into revenue-generating products and market-leading positions.

Throughout his career, Fernando has held senior executive roles with full P&L responsibility, partnering with boards and leadership teams to accelerate go-to-market execution, secure commercial partnerships, and scale organizations for growth. He is widely recognized for turning breakthrough innovations into commercially successful products in complex, regulated industries.

As a board director, Fernando will provide strategic oversight on commercial execution, revenue growth, and market expansion, strengthening governance and accelerating the company’s commercialization of its food colorant portfolio.

“Fernando’s decision to join our Board after working closely with us for more than two years reflects strong alignment and trust,” said Ricky Cassini, CEO and Founder of Michroma. “His experience in global ingredient and food color markets will be instrumental as we sharpen our execution and market focus.”

Fernando Miquelarena added, “Having worked with Michroma over the past two years, I’ve seen the strength of the team and the growing opportunity in natural food colorants. I’m excited to support the company at the board level as it continues to scale.”

About Michroma: Michroma is a biotechnology company developing high-performance, scalable natural food colorants using precision fermentation. The company focuses on delivering reliable color performance, manufacturability, and scalability for food and consumer goods applications. Headquartered in San Francisco, with operations in Argentina, Michroma works with industry partners to bring fermentation-derived color solutions from development to commercial scale. www.michroma.co

Media Contact: [email protected]

Cision View original content:https://www.prnewswire.com/news-releases/fernando-miquelarena-joins-michroma-as-independent-board-director-302671761.html

SOURCE Michroma

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Cashing In On University Patents Means Giving Up On Our Innovation Future

Cashing In On University Patents Means Giving Up On Our Innovation Future

The post Cashing In On University Patents Means Giving Up On Our Innovation Future appeared on BitcoinEthereumNews.com. “It’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress,” writes Pipes. Getty Images Washington is addicted to taxing success. Now, Commerce Secretary Howard Lutnick is floating a plan to skim half the patent earnings from inventions developed at universities with federal funding. It’s being sold as a way to shore up programs like Social Security. In reality, it’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress. Yes, taxpayer dollars support early-stage research. But the real payoff comes later—in the jobs created, cures discovered, and industries launched when universities and private industry turn those discoveries into real products. By comparison, the sums at stake in patent licensing are trivial. Universities collectively earn only about $3.6 billion annually in patent income—less than the federal government spends on Social Security in a single day. Even confiscating half would barely register against a $6 trillion federal budget. And yet the damage from such a policy would be anything but trivial. The true return on taxpayer investment isn’t in licensing checks sent to Washington, but in the downstream economic activity that federally supported research unleashes. Thanks to the bipartisan Bayh-Dole Act of 1980, universities and private industry have powerful incentives to translate early-stage discoveries into real-world products. Before Bayh-Dole, the government hoarded patents from federally funded research, and fewer than 5% were ever licensed. Once universities could own and license their own inventions, innovation exploded. The result has been one of the best returns on investment in government history. Since 1996, university research has added nearly $2 trillion to U.S. industrial output, supported 6.5 million jobs, and launched more than 19,000 startups. Those companies pay…
Share
BitcoinEthereumNews2025/09/18 03:26
Trump foe devises plan to starve him of what he 'craves' most

Trump foe devises plan to starve him of what he 'craves' most

A longtime adversary of President Donald Trump has a plan for a key group to take away what Trump craves the most — attention. EX-CNN journalist Jim Acosta, who
Share
Rawstory2026/02/04 01:19
Why Bitcoin Is Struggling: 8 Factors Impacting Crypto Markets

Why Bitcoin Is Struggling: 8 Factors Impacting Crypto Markets

Failed blockchain adoption narratives and weak fee capture have undercut confidence in major crypto projects.
Share
CryptoPotato2026/02/04 01:05